Bevacizumab in Treating Patients With Advanced Solid Tumors

NCT00416637 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: Bevacizumab (Avastin)

Sponsor

Herbert Hurwitz, MD

Collaborators

[object Object]